RESUMO
Bone injury occurs in human hemolytic disorders associated with thrombosis, such as beta-thalassemia and sickle cell disease. Exposure of rats to 2-butoxyethanol (BE) has been associated with hemolytic anemia, disseminated thrombosis, and infarction in multiple organs including bone. This rat model apparently mimics acute hemolysis and thrombosis in humans. To elucidate the extent of bone injury, male and female Fischer F344 rats were given 4 daily doses of 250 mg BE/5 ml water/kg of body weight. Tail vertebrae were studied by histopathology and magnetic resonance imaging (MRI). Thrombosis and infarction were seen in both sexes, but females were more severely affected. Lesions were characterized by extensive medullary fat necrosis, granulomatous inflammation, fibroplasia, growth plate degeneration, and new woven bone formation adjacent to necrotic bone trabeculae. MRI mean and standard deviation tissue-density data for both sexes indicated a significant (P < or = 0.05) decrease following 4-days treatment and a significant increase (P < or = 0.05) following an additional 24 days without treatment. Thus, MRI was useful in revealing BE-induced bone injury, which was predominantly necrotic initially and subsequently regenerative with proliferation of connective tissue and bone following postischemia recovery.
Assuntos
Modelos Animais de Doenças , Hemólise/efeitos dos fármacos , Osteonecrose/induzido quimicamente , Trombose/induzido quimicamente , Animais , Etilenoglicóis/toxicidade , Feminino , Imageamento por Ressonância Magnética , Masculino , Osteonecrose/patologia , Ratos , Ratos Endogâmicos F344 , Fatores Sexuais , Solventes/toxicidade , Coluna Vertebral/efeitos dos fármacos , Coluna Vertebral/patologia , Cauda/efeitos dos fármacos , Cauda/patologia , Trombose/patologiaRESUMO
2-butoxyethanol (BE; ethylene glycol monobutyl ether) is used extensively in the manufacture of a wide range of domestic and industrial products which may result in human exposure and toxicity. BE causes severe hemolytic anemia in male and female rats and mice. In a recent report, female F344 rats exposed to 500 ppm BE by inhalation and sacrificed moribund on day 4 of treatment exhibited disseminated thrombosis associated with infarction in several organs. In contrast, no such lesions were observed in male rats similarly exposed to BE. Additional studies were therefore undertaken to compare the effects of BE in rats of both sexes. Rats received 250 mg BE/kg/day by gavage for 1, 2 or 3 days and were sacrificed 24 or 48 hr after the last dose. Control rats received 5 ml/kg water. Progressive time-dependent hemolytic anemia--macrocytic, hypochromic, and regenerative--was observed in both sexes of rats exposed to BE. Additionally, BE caused significant morphological changes in erythrocytes, first observed 24 hr after a single dose, including stomatocytosis, macrocytosis with moderate rouleaux formation, and spherocytosis. These morphological changes became progressively more severe as BE dosing continued and included the occasional occurrence of schistocytes and ghost cells, rouleaux formation in rats of both sexes, and an increased number of red blood cells with micronuclei in female rats. Overall, the progression of hemolytic anemia and morphological changes as a function of the number of days of exposure varied with gender and suggested a faster onset of hemolysis in female rats. The range of BE-related histopathological changes noted in both sexes was comparable; however, while these lesions were observed in female rats following a single dose, similar effects were first observed in males after 3 consecutive days of exposure to BE. Pathological changes involved disseminated thrombosis in the lungs, nasal submucosa, eyes, liver, heart, bones and teeth, with evidence of infarction in the heart, eyes, teeth and bones. Hemoglobinuric nephrosis and splenic extramedullary hematopoiesis were also noted. An apparent correlation between the severity of hemolytic anemia and subsequent disseminated thrombosis in BE-treated rats is proposed. Thrombosis may be related to intravascular hemolysis, which could be triggered by procoagulant release and/or alterations in erythrocyte morphology, as well as increased rigidity.
Assuntos
Anemia Hemolítica/induzido quimicamente , Etilenoglicóis/toxicidade , Infarto/induzido quimicamente , Solventes/toxicidade , Trombose/induzido quimicamente , Administração Oral , Anemia Hemolítica/patologia , Anemia Hipocrômica/induzido quimicamente , Anemia Hipocrômica/patologia , Anemia Macrocítica/induzido quimicamente , Anemia Macrocítica/patologia , Animais , Eritrócitos/efeitos dos fármacos , Eritrócitos/patologia , Etilenoglicóis/administração & dosagem , Feminino , Fêmur/efeitos dos fármacos , Fêmur/patologia , Hemólise/efeitos dos fármacos , Infarto/patologia , Masculino , Odontoblastos/efeitos dos fármacos , Odontoblastos/patologia , Ratos , Ratos Endogâmicos F344 , Fatores Sexuais , Solventes/administração & dosagem , Trombose/patologia , Dente/efeitos dos fármacos , Dente/patologiaRESUMO
Female Fischer 344 (F344)/N rats (10 per exposure group) were exposed to 2-butoxyethanol (BE) vapors (0, 31, 62.5, 125, 250, or 500 ppm 6 h/d, 5 d/wk, for 13 weeks) to characterize its prechronic toxicity. Dental lesions consisting of bilateral multifocal dental pulp thrombosis, pulp infarction, and odontoblast infarction were noted in the maxillary incisors of 3 of 4 rats from the 500-ppm group that were sacrificed when moribund during the first week of exposure. In addition, 1 rat from the 500-ppm group that was sacrificed on day 32 had similar unilateral incisor lesions but with additional findings consistent with a unilateral maxillary incisor fracture. In contrast, rats sacrificed after 13 weeks of exposure lacked dental lesions. In conclusion, BE has the potential to cause pulp thrombosis and odontoblast infarction in female rats. The apparent variability in response to BE noted in moribund sacrificed vs terminally sacrificed rats was attributed to development of tolerance to BE-induced hemolysis and subsequent incisor regeneration.
Assuntos
Polpa Dentária/irrigação sanguínea , Etilenoglicóis/toxicidade , Infarto/induzido quimicamente , Solventes/toxicidade , Administração por Inalação , Animais , Contagem de Células Sanguíneas/efeitos dos fármacos , Polpa Dentária/patologia , Feminino , Incisivo/irrigação sanguínea , Incisivo/efeitos dos fármacos , Incisivo/patologia , Infarto/patologia , Ratos , Ratos Endogâmicos F344RESUMO
Groups of 10 male and 10 female F344/N rats were exposed to 0, 31, 62.5, 125, 250, and 500 ppm of 2-butoxyethanol (BE) by inhalation, 6 hr/day, 5 days/wk, for 13 wk. Four moribund female rats from the 500 ppm group were sacrificed during the first 4 days of exposure, and 1 moribund female from the same group was sacrificed during week 5. Dark irregular mottling and/or loss of the distal tail were noted in sacrificed moribund rats. Similar gross lesions were noted in the terminally sacrificed females exposed to 500 ppm BE. Histologic changes noted in the day 4 sacrificed moribund rats included disseminated thrombosis involving the coccygeal vertebrae, cardiac atrium, lungs, liver, pulp of the incisor teeth, and the submucosa of the anterior section of the nasal cavity. Alterations noted in coccygeal vertebrae from the 500 ppm sacrificed moribund rats included ischemic necrosis and/or degeneration of bone marrow cells, bone-lining cells, osteocytes (within cortical and trabecular bone), and chondrocytes (both articular and growth plate), changes that are consistent with an infarction process. The moribund female rat that was sacrificed during week 5 and those female rats treated with 500 ppm and sacrificed following 13 wk of treatment lacked thrombi, but they had coccygeal vertebral changes consistent with prior infarction and transient or complete bone growth arrest. No bone lesions or thrombi were noted in the male rats treated with the same doses of BE. In conclusion, exposure to 500 ppm BE vapors caused acute disseminated thrombosis and bone infarction in female rats. Possible pathogenic mechanisms are discussed.
Assuntos
Coagulação Intravascular Disseminada/induzido quimicamente , Etilenoglicóis/toxicidade , Osteonecrose/induzido quimicamente , Solventes/toxicidade , Administração por Inalação , Animais , Etilenoglicóis/administração & dosagem , Feminino , Infarto/patologia , Masculino , Cavidade Nasal/patologia , Osteonecrose/patologia , Ratos , Ratos Endogâmicos F344 , Solventes/administração & dosagem , Trombose/induzido quimicamente , Trombose/patologiaRESUMO
A 2-month-old male black and white Colobus monkey (Colobus guereza kikuyuensis) was euthanatized because of progressive physical deterioration, rear limb paralysis, lymphadenopathy, and the presence of facial and retroperitoneal lumbar masses. At necropsy, soft white masses were present in and around lumbar vertebrae, the subcutis of the face, multiple lymph nodes, and the fourth ventricle of the brain. Histologic and immunohistochemical analysis of these masses revealed a primitive neoplasm with both neuronal and glial differentiation, consistent with a primitive neuroectodermal tumor (PNET) with bipotential differentiation. The extracranial tumors were synaptophysin (SYN)-positive, glial fibrillary acidic protein (GFAP)-negative, and neurofilament protein (NFP)-negative, while the intracranial tumor was SYN-positive, GFAP-positive, and NFP-negative.
Assuntos
Neoplasias Encefálicas/veterinária , Colobus , Doenças dos Macacos , Tumores Neuroectodérmicos/veterinária , Animais , Animais de Zoológico , Biomarcadores/análise , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/fisiopatologia , Proteína Glial Fibrilar Ácida/análise , Masculino , Tumores Neuroectodérmicos/patologia , Tumores Neuroectodérmicos/fisiopatologia , Proteínas de Neurofilamentos/análise , Sinaptofisina/análiseRESUMO
Female guinea pigs (12/group) were given a single dose of [14C]olestra by gavage after consuming either 3% poligeenan in tap water (Compromised group) or just tap water (Normal group) for 5 weeks. A Sentinel group (N = 2) was given 3% poligeenan for 5 weeks. Ten sentinel animals were killed 1 day before and 10 1 day after the other animals were dosed with [14C]olestra and their gastrointestinal tracts were examined by histology. The Compromised and Normal animals were endoscoped just before dosing with [14C]olestra. Urine and feces were collected continuously and CO2 was collected for 7 days after dosing. The samples were analyzed for 14C and urine was also analyzed for [14C]sucrose. Animals (3/group) were killed 1, 3, 7, and 21 days after dosing, and tissues were collected and assayed for 14C. Tissue lipids were extracted, fractionated by high-pressure liquid chromatography, and analyzed for [14C]olestra by liquid scintillation. Animals fed poligeenan showed mucosal edema, congestion, ulceration, and fibrin deposition within the distal colon and rectum. Histology revealed inflammation, epithelial degeneration, and multifocal ulceration of the cecum, distal colon, and rectum. The gastrointestinal mucosae of nonpoligeenan fed animals were normal. No [14C]olestra was detected in liver lipids and no [14C]sucrose was found in the urine for any animal in the Normal or Compromised groups, indicating that intact olestra was not absorbed. The amount, distribution, and elimination of absorbed 14C did not differ between guinea pigs with normal and compromised gastrointestinal tracts. The poligeenan-treated animals displayed mucosal damage similar to that seen in human inflammatory bowel diseases; therefore, these results suggest that patients with inflammatory bowel conditions will not absorb olestra to any greater extent than normal healthy people.
Assuntos
Gorduras Insaturadas na Dieta/metabolismo , Substitutos da Gordura/metabolismo , Ácidos Graxos/metabolismo , Absorção Intestinal , Sacarose/análogos & derivados , Administração Oral , Ração Animal , Animais , Radioisótopos de Carbono , Colo/efeitos dos fármacos , Colo/patologia , Gorduras Insaturadas na Dieta/administração & dosagem , Modelos Animais de Doenças , Ingestão de Líquidos , Endoscopia , Substitutos da Gordura/administração & dosagem , Ácidos Graxos/administração & dosagem , Feminino , Gastroenteropatias/induzido quimicamente , Cobaias , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/patologia , Polissacarídeos , Reto/efeitos dos fármacos , Reto/patologia , Sacarose/administração & dosagem , Sacarose/metabolismo , Extratos de Tecidos/análiseRESUMO
Olestra is a class of sucrose-fatty acid polyesters intended for use as a non-caloric replacement of edible oil. Genotoxicity and subchronic toxicity studies were conducted to determine whether olestra could form genotoxic or toxic breakdown products during simulated commercial use. Heated olestra was prepared for these studies by batch-frying potato slices in olestra at 177-185 degrees C for 25-32 hr over 5-7 days. Genotoxicity of this previously heated olestra was assessed in four standard in vitro assays: (1) Salmonella mutagenesis (Ames test); (2) forward mutagenesis of mouse lymphoma cells at the thymidine kinase locus; (3) unscheduled DNA synthesis in rat hepatocytes; and (4) clastogenicity in cultured Chinese hamster ovary cells. These tests were conducted with previously heated olestra at concentrations up to at least 5 mg/ml both in the absence of exogenous bioactivation and, for assays (1), (2) and (4) with added liver microsomal (S-9) activation. The Ames and mouse lymphoma assays were performed with olestra (10 mg/ml and 23 mg/litre, respectively) either alone or emulsified with the non-toxic, non-ionic surfactant Pluronics F68, both in the presence and absence of metabolic activation. To test for clastogenicity in vivo, rats were administered previously heated olestra by gavage at 5 g/kg per day for up to 5 days and bone marrow cells were examined for chromosomal aberrations. Heated olestra lacked genotoxic activity detectable by the aforementioned assays. Heated olestra was fed to Fischer 344 rats at up to 10% of the diet (w/w) for 91 days. Evaluation of survival, food consumption, feed efficiency, physical condition, body weight, organ weight, haematological and clinical chemistry parameters, and histomorphology revealed no adverse effects attributable to ingestion of heated olestra at exposure levels in excess of those anticipated for human consumption. It is concluded that olestra used as a deep-frying medium conveys no genotoxic or toxic hazard at anticipated levels of human consumption.
Assuntos
Gorduras Insaturadas na Dieta/toxicidade , Ácidos Graxos/toxicidade , Sacarose/análogos & derivados , Animais , Células CHO/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Divisão Celular/genética , Células Cultivadas , Aberrações Cromossômicas/genética , Cricetinae , Cricetulus , DNA/biossíntese , Gorduras Insaturadas na Dieta/metabolismo , Sinergismo Farmacológico , Ácidos Graxos/metabolismo , Temperatura Alta , Fígado/citologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Linfoma/enzimologia , Linfoma/patologia , Masculino , Camundongos , Testes de Mutagenicidade , Ratos , Ratos Endogâmicos F344 , Ratos Sprague-Dawley , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética , Sacarose/metabolismo , Sacarose/toxicidade , Tensoativos/metabolismo , Tensoativos/toxicidade , Timidina Quinase/metabolismo , Células Tumorais CultivadasRESUMO
Two 2-yr feeding studies were conducted in Swiss CD-1 mice to evaluate the oral toxicity and carcinogenicity potential of olestra, a fat substitute consisting of a mixture of the hexa-, hepta- and octaesters of sucrose formed with long-chain fatty acids. In a dose-response study olestra was fed at 0, 2.5, 5 or 10% (w/w) of the diet. In a companion study conducted to confirm equivocal effects, olestra was fed at 0 or 10% (w/w) of the diet. Olestra-containing diets were supplemented with fat-soluble vitamins A, D, E and K to maintain the nutritional status of the olestra-fed mice at a level similar to that of the control mice. 100 mice/sex were placed in each group. 50 mice/sex/group were predesignated to the carcinogenicity portion of the study and all survivors were killed at 24 months. 15 mice/sex/group were predesignated to the toxicity portion of the study and were killed at 12 months. 35 mice/sex/group were included as sentinel animals to be used for monitoring nutritional status. Ophthalmoscopic examinations were conducted before the test and at 12 and 24 months. Body weights and feed consumption were determined weekly. Gross observations, clinical chemistry and haematology data were obtained on animals killed at 12 and 24 months. Complete gross post-mortem examinations, including organ weight and organ-to-body and organ-to-brain weight ratios were performed on all animals. Histopathology was conducted on a full complement of tissues from all animals allocated to the carcinogenicity portions of the studies. There were no olestra-related effects on any of the endpoints measured, including survival, time-to-tumour or tumour incidence, ophthalmology, clinical chemistry, haematology, organ weights or tissue morphology. These results indicate that olestra is not toxic or carcinogenic when fed to mice at up to 10% of the diet for 2 yr.
Assuntos
Carcinógenos/toxicidade , Ácidos Graxos/toxicidade , Sacarose/análogos & derivados , Animais , Análise Química do Sangue , Testes de Carcinogenicidade , Dieta , Feminino , Masculino , Camundongos , Sacarose/toxicidade , Vitaminas/análiseRESUMO
Bilateral, multicentric renal tubule tumors were found in 4 rats at the termination of 3 separate 90-day toxicity studies during the safety evaluation of 3 unrelated chemicals. The 3 studies were conducted at 2 separate locations, but the rats used were obtained from the same commercial source. The rat strains were Fischer-344 (1 male and 1 female case) and Sprague-Dawley (2 female cases). Three of the renal tumor cases were from either the high-dose or mid-dose treatment groups, and 1 case was an untreated control. The tumors were accompanied by multiple foci of atypical tubule hyperplasia but only in the tumor-bearing rats. There were no lesions associated with renal tumor pathogenesis in any of the remaining treated or untreated animals in the 3 studies. In addition, there was no indication of nephrotoxicity in the treated or untreated animals. Tumor morphology was characterized by a generally vacuolated appearance, eosinophilia, cytoplasmic and nuclear pleomorphism, and conspicuously hypertrophied nucleoli. The renal tubule tumors in these 90-day studies were compared to hereditary renal tubule tumors occurring in the Eker rat, a Long-Evans derivative with a genetic predisposition to this tumor type. The multiplicity of renal tubule tumors, early age of onset, and tumor morphology described in the cases from the 90-day studies were very similar to those characterizing the hereditary renal tumor model.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Neoplasias Renais/veterinária , Túbulos Renais/patologia , Doenças dos Roedores/patologia , Testes de Toxicidade , Adenoma/veterinária , Animais , Testes de Carcinogenicidade , Carcinoma/veterinária , Feminino , Hiperplasia/veterinária , Neoplasias Renais/induzido quimicamente , Neoplasias Renais/patologia , Masculino , RatosRESUMO
Groups of young, sexually mature Fischer-344 rats (n = 25/sex) obtained from commercial breeders were examined ophthalmologically and histopathologically to determine the prevalence and severity of corneal basement membrane lesions (corneal dystrophy) and basement membrane changes in select nonocular tissues. Results disclosed a high incidence of corneal basement membrane dystrophy in rats of both sexes from all breeders; however, severity levels were significantly increased in rats obtained from one breeder when compared to others. Furthermore, rats that displayed the most advanced corneal lesions also exhibited more severe basement membrane changes in other organs, especially renal tubules and vascular internal laminae. These findings suggest that both ocular and nonocular dystrophic changes may have been linked through common physiologic (or genetic) mechanisms. Animals that displayed basement membrane lesions were not considered to represent compromised biologic test systems.
Assuntos
Doenças da Córnea/patologia , Animais , Membrana Basal/patologia , Vasos Sanguíneos/patologia , Feminino , Rim/patologia , Masculino , Ratos , Ratos Endogâmicos F344 , Estômago/patologiaRESUMO
The cause of a fatal condition characterized by hemorrhagic cardiomyopathy, hemothorax, and coagulation defects in hysterectomy-derived male mice was investigated. Microscopic heart alterations included multifocal hemorrhage and necrosis with variable degrees of acute inflammation and fibroplasia that were most severe in the region of the atrioventricular junction. A spontaneous outbreak was arrested by increasing menadione Na-bisulfite (vitamin K) in the feed to 20 ppm. The complete syndrome including hemorrhagic cardiomyopathy was readily reproduced in germ-free male mice given a vitamin K-free diet, and in conventional male and female mice given Warfarin in the diet. We concluded that the cause of this condition was vitamin K deficiency.
Assuntos
Cardiomiopatias/etiologia , Transtornos Hemorrágicos/etiologia , Hemotórax/etiologia , Deficiência de Vitamina K/complicações , Animais , Transtornos da Coagulação Sanguínea/etiologia , Cardiomiopatias/dietoterapia , Feminino , Transtornos Hemorrágicos/dietoterapia , Hemotórax/dietoterapia , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Miocárdio/patologia , Vitamina K/farmacocinética , Vitamina K/farmacologia , Varfarina/efeitos adversosRESUMO
A 91-day feeding study in rats was conducted to assess the potential toxicity of heated olestra/vegetable oil blends. Olestra is a mixture of the hexa-, hepta- and octa- long-chain fatty acid esters of sucrose. The blends tested were 35/65 olestra/vegetable oil (w/w), pan-fried at 380 degrees F for 30 min to simulate home-use conditions and 75/25 olestra/vegetable oil, deep-fried at 365 degrees F for 84 hr to simulate extended food-service use. Vegetable oil, prepared using both heating conditions, unheated vegetable oil and unheated olestra/vegetable oil blends served as controls. The olestra/vegetable oil blends and vegetable-oil control were generally fed at 10% (w/w) of the diet. Two further groups received the heated olestra/vegetable oil blends at 5% of the diet. Survival, clinical signs, body weight, feed consumption, feed conversion efficiency, organ weights, organ-to-body-weight ratios, haematological parameters and histomorphology were evaluated. No adverse effects from the ingestion of heated olestra/vegetable oil blends were detected. These findings indicate that heated olestra was non-toxic and, in this respect, no different from unheated olestra or heated or unheated vegetable oil.
Assuntos
Culinária , Gorduras Insaturadas na Dieta/administração & dosagem , Ácidos Graxos/administração & dosagem , Óleos de Plantas/administração & dosagem , Sacarose/análogos & derivados , Animais , Peso Corporal/efeitos dos fármacos , Ingestão de Energia/efeitos dos fármacos , Ácidos Graxos/toxicidade , Feminino , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/patologia , Linfonodos/efeitos dos fármacos , Linfonodos/patologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Óleos de Plantas/toxicidade , Ratos , Ratos Endogâmicos , Sacarose/administração & dosagem , Sacarose/toxicidadeRESUMO
1,25-(OH)2 vitamin D3 (D3) and sodium fluoride (NaF) were given to chicken embryos and newly hatched chickens infected with a slow onset strain of avian osteopetrosis-inducing virus [MAV-2(O)] to determine if either agent influenced MAV-2(O)-induced proliferation of bone. Embryos were administered MAV-2(O) and treated with: 1) up to 240 micrograms NaF or up to 100 ng D3 as embryos; 2) up to 1.8 g NaF/kg or up to 9.5 micrograms D3/kg after hatching: or 3) 240 micrograms NaF as embryos and up to 1.8 g NaF/kg after hatching. Administration of MAV-2(O) alone resulted in expansion of the cortical diameter of bone. Coadministration of NaF or D3 with MAV-2(O) did not influence the change in cortical diameter seen with MAV-2(O) alone at 18 days of incubation, and 3 and 6 weeks after hatching. Increased osteoid relative to bone (hyperosteoidosis), with NaF and MAV-2(O) compared to MAV-2(O) alone, and NaF compared to untreated controls reflected delayed mineralization of osteoid, a known fluoride effect. We conclude that the administration of NaF or D3 did not influence the incidence, severity or time of onset of the MAV-2(O)-induced proliferative changes of bone.
Assuntos
Osso e Ossos/efeitos dos fármacos , Calcitriol/farmacologia , Osteopetrose/veterinária , Doenças das Aves Domésticas/etiologia , Infecções por Retroviridae/veterinária , Fluoreto de Sódio/farmacologia , Animais , Osso e Ossos/patologia , Divisão Celular/efeitos dos fármacos , Embrião de Galinha , Galinhas , Osteopetrose/etiologia , Osteopetrose/patologia , Doenças das Aves Domésticas/patologia , Infecções por Retroviridae/patologiaRESUMO
Studies were undertaken to assess the chicken embryo and newly hatched chicken as models for studying the effects of bone-active agents. Initially, 1,25-dihydroxycholecaliferol (1,25[OH]2D3), sodium fluoride (NaF), parathyroid extract, epidermal growth factor, and prostaglandin E2, were tested for lethality over a broad dose range. One or 3 injections of 1,25(OH)2D3 into the yolk sac of chicken embryos resulted in death of embryos given greater than or equal to 0.1 ng/injection, whereas 0.01 ng was tolerated by the embryos. Administering 1,25(OH)2D3 intraperitoneally to newly hatched chickens as a single injection or weekly for 3 weeks resulted in no deaths at doses up to 50 ng. One or 3 IV injections of 800 micrograms of NaF were lethal to embryos, whereas injections of less than or equal to 400 micrograms were tolerated by the embryo. Giving chickens feed and water containing 2.4 g of NaF/kg was lethal, but no deaths occurred when chickens were given feed containing less than or equal to 1.2 g of NaF/kg. Mortality associated with the administration of epidermal growth factor to embryos was inconsistent, in that death occurred in embryos given a single injection of greater than or equal to 250 ng, but no deaths occurred in embryos given 3 injections at similar doses. Parathyroid extract and prostaglandin E2 were not lethal when administered to embryos and chickens in a single-injection or multiple-injection regimen. Overall, lethality in chicken embryos given a particular agent reflected the dose of bone-active agent injected, rather than the number of injections. Three of the bone-active agents were selected to characterize their microscopic bone effects in chicken embryos and chickens.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Doenças Ósseas/veterinária , Osso e Ossos/efeitos dos fármacos , Embrião de Galinha/efeitos dos fármacos , Galinhas , Doenças das Aves Domésticas/induzido quimicamente , Animais , Desenvolvimento Ósseo/efeitos dos fármacos , Doenças Ósseas/induzido quimicamente , Osso e Ossos/embriologia , Calcitriol/toxicidade , Dinoprostona/toxicidade , Fator de Crescimento Epidérmico/toxicidade , Glândulas Paratireoides , Fluoreto de Sódio/toxicidade , Tíbia , Extratos de Tecidos/toxicidadeRESUMO
Ethylenediaminetetra(methylenephosphonic acid), EDITEMPA, was tested for oral toxicity in rats in a 13-wk feeding study (at doses of 0, 5, 50 and 500 mg/kg/day) and in a chronic feeding study (at doses of 0, 4, 20 and 100 mg/kg/day). EDITEMPA was also tested for genotoxicity in the Ames, mouse lymphoma, unscheduled DNA synthesis, and in vivo cytogenetics assays. Additionally, absorption, distribution and excretion (ADE) studies were conducted following administration of [14C]EDITEMPA to rats by gavage and via the feed and drinking-water. The principal finding in the 13-wk study was mild anaemia in male and female rats given 500 mg/kg/day, which was resolved during a 9-wk recovery period. In the chronic study, there was no substantial evidence of any treatment-related toxicity or carcinogenicity. Differences in survival of control and treated females (noted late in the study) were interpreted to represent unusually good survival in controls; however, a compound-related increase in mortality could not be completely ruled out. Tests for genotoxicity were all negative. ADE studies revealed that [14C]EDITEMPA was poorly absorbed from the gastro-intestinal tract and that most of the absorbed dose was rapidly excreted by the kidneys or sequestered in bone. The gavage route of administration led to four- to six-fold increases in bone EDITEMPA levels as compared with administration in the feed and drinking-water, respectively. These results suggest that no significant toxicity or carcinogenicity concerns arise from EDITEMPA when it is administered in the feed at the concentrations tested. Reversible anaemia was seen only at very high doses and was interpreted as being secondary to EDITEMPA's ability to interfere with iron absorption and utilization. Localization of EDITEMPA in bone indicated a high degree of affinity for mineralizing tissues, consistent with its chelating properties. There was, however, no effect on bone resorption or mineralization. A comparison of human drinking-water levels of 3500 ppm EDITEMPA (based on a no-effect level of 100 mg/kg/day in rats) with the estimated worst-case exposure in humans of 0.01 ppm suggested a safety margin greater than 1 x 10(5).
Assuntos
Compostos Organofosforados/toxicidade , Administração Oral , Anemia/induzido quimicamente , Animais , Peso Corporal/efeitos dos fármacos , Osso e Ossos/metabolismo , DNA/biossíntese , Fezes/análise , Feminino , Rim/metabolismo , Dose Letal Mediana , Masculino , Camundongos , Testes de Mutagenicidade , Neoplasias Experimentais/induzido quimicamente , Compostos Organofosforados/farmacocinética , Ratos , Ratos Endogâmicos F344 , Ratos Endogâmicos , Distribuição TecidualAssuntos
Erros Inatos do Metabolismo/veterinária , Coelhos , Glândulas Suprarrenais/patologia , Animais , Histocitoquímica , Intestino Delgado/patologia , Intestino Delgado/ultraestrutura , Fígado/patologia , Fígado/ultraestrutura , Linfonodos/patologia , Masculino , Erros Inatos do Metabolismo/patologia , Microscopia Eletrônica , Pâncreas/patologiaRESUMO
Light microscopic, ultrastructural, and microbiologic evaluations were performed on stomachs from 30 healthy laboratory-reared Beagles. Spiral-shaped microorganisms were seen in the gastric glands and parietal cell canaliculi of all the dogs. Organisms were most numerous in the cardia and in the region of the fundic-pyloric junction. Lymphoreticular hyperplasia, dilatation of parietal cell canaliculi, and degeneration of individual parietal cells (rarely seen) were the only morphologic alterations seen. Organisms were helical, had tufts of flagella at each end, and were approximately 0.5 X 7.0 micron; some had a distinct axial fibril (indicating two distinct forms of the organism). Attempts to propagate a viable culture of the organism were not successful. The organism most closely resembled those of the genus Spirillum. Because the organism was commonly found in the gastric mucosa of healthy Beagles, it probably should be considered part of the natural gastric flora of dogs.